[Diagnostic and therapeutic strategy of Zollinger-Ellison syndrome. Groupe de Recherches et d'Etudes du Syndrome de Zollinger-Ellison (GRESZE)]

Ann Chir. 1994;48(6):535-46.
[Article in French]

Abstract

The current strategy recommended for Zollinger-Ellison syndrome (ZES) has significantly improved the outcome of this condition. Diagnosis is based on determinations of basal and post-secretin gastric acid output and serum gastrin levels. A crucial step is differentiation of patients with sporadic ZES from those with multiple endocrine neoplasia type 1 syndrome. Only the former should undergo excision of the tumor when feasible. All available imaging techniques should be used pre- and intra-operatively to detect tumorous lesions. Exploratory laparatomy is warranted in patients who have sporadic ZES without evidence of liver metastases.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Gastric Acidity Determination
  • Histamine H2 Antagonists / therapeutic use
  • Humans
  • Multiple Endocrine Neoplasia Type 1 / complications
  • Multiple Endocrine Neoplasia Type 1 / diagnosis*
  • Multiple Endocrine Neoplasia Type 1 / therapy
  • Proton Pump Inhibitors
  • Somatostatin / analogs & derivatives
  • Zollinger-Ellison Syndrome / complications
  • Zollinger-Ellison Syndrome / diagnosis*
  • Zollinger-Ellison Syndrome / physiopathology
  • Zollinger-Ellison Syndrome / therapy

Substances

  • Histamine H2 Antagonists
  • Proton Pump Inhibitors
  • Somatostatin